TrialSurgery today2016

Concurrent gemcitabine+S-1 neoadjuvant chemotherapy contributes to the improved survival of patients with small borderline-resectable pancreatic cancer tumors.

Toshihiko Masui et al.PubMed ↗Publisher ↗

No numbers read from the abstract.